Sign In
Buy PROG
$0.94
-0.0340 (-3.48%)
At Close: Aug 17, 2022
Progenity Receives Funding from Crohn's & Colitis Foundation IBD Ventures Fund to Develop Drug Delivery System for IBD
07:30am, Tuesday, 11'th May 2021
SAN DIEGO, May 11, 2021 (GLOBE NEWSWIRE) -- Progenity, Inc. (Nasdaq: PROG), a biotechnology company with an established track record of success developing and commercializing molecular testing product
Progenity to Report First Quarter 2021 Financial Results and Provide Corporate Update
07:30am, Thursday, 06'th May 2021
SAN DIEGO, May 06, 2021 (GLOBE NEWSWIRE) -- Progenity, Inc. (NASDAQ: PROG), a biotechnology company with an established track record of success in developing and commercializing molecular testing prod
Progenity Provides Key Update Regarding its Preecludia™ Test for Preeclampsia
07:30am, Wednesday, 05'th May 2021
Pre-validation study demonstrates commercial laboratory systems readiness; data show strong performance consistent with verification study Pre-validation study demonstrates commercial laboratory syste
Survey Reveals Pregnant Women Lack Awareness About Preeclampsia, the #2 Cause of Maternal Death
07:30am, Tuesday, 04'th May 2021
Progenity survey shows more women know their baby's “fruit size” than the key indicator of a common pregnancy complication
Data demonstrate strong sensitivity and negative predictive value (NPV) Data demonstrate strong sensitivity and negative predictive value (NPV)
Progenity to Present Two Abstracts for Novel Ingestible Drug Delivery Technologies at Digestive Disease Week 2021
07:30am, Monday, 26'th Apr 2021
SAN DIEGO, April 26, 2021 (GLOBE NEWSWIRE) -- Progenity, Inc. (Nasdaq: PROG), a biotechnology company with an established track record of success in developing and commercializing molecular testing pr
SAN DIEGO, April 08, 2021 (GLOBE NEWSWIRE) -- Progenity, Inc. (Nasdaq: PROG), a biotechnology company with an established track record of success developing and commercializing molecular testing produ
Johnson Fistel Investigates Progenity; Should Management be Held Accountable for Investors Losses?
09:58am, Saturday, 27'th Mar 2021
SAN DIEGO, March 27, 2021 /PRNewswire/ -- Johnson Fistel, LLP is investigating potential claims on behalf of Progenity, Inc. (NASDAQ: PROG) against certain of its officers and directors. In June 202
Progenity, Inc. (PROG) CEO Dr. Harry Stylli on Q4 2020 Results - Earnings Call Transcript
10:04pm, Thursday, 18'th Mar 2021
Progenity, Inc. (PROG) CEO Dr. Harry Stylli on Q4 2020 Results - Earnings Call Transcript
Progenity Provides Corporate Updates and Reports Fourth Quarter and Full-Year 2020 Financial Results
04:05pm, Thursday, 18'th Mar 2021
Reports approximately 82,000 tests in the fourth quarter of 2020
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Progenity, Inc. - PROG
10:43pm, Sunday, 14'th Mar 2021
New York, New York--(Newsfile Corp. - March 14, 2021) - Pomerantz LLP is investigating claims on behalf of investors of Progenity, Inc. ("Silk Road" or the "Company") (NASDAQ: PROG). Such investors ar
Progenity to Report Fourth Quarter and Full Year 2020 Financial Results and Provide Corporate Update
07:30am, Friday, 12'th Mar 2021
SAN DIEGO, March 12, 2021 (GLOBE NEWSWIRE) -- Progenity, Inc. (NASDAQ: PROG), a biotechnology company with an established track record of success in developing and commercializing molecular testing pr
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Progenity, Inc. - PROG
04:40am, Friday, 12'th Mar 2021
NEW YORK, March 12, 2021 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Progenity, Inc. ("Silk Road" or the "Company") (NASDAQ: PROG). Such investors are advised
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Progenity, Inc. - PROG
01:37pm, Sunday, 07'th Mar 2021
New York, New York--(Newsfile Corp. - March 7, 2021) - Pomerantz LLP is investigating claims on behalf of investors of Progenity, Inc. ("Silk Road" or the "Company") (NASDAQ: PROG). Such investors are
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Progenity, Inc. - PROG
03:10am, Wednesday, 03'rd Mar 2021
NEW YORK, March 3, 2021 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Progenity, Inc. ("Silk Road" or the "Company") (NASDAQ: PROG). Such investors are advised to con
